BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 33308128)

  • 1. Cell Free DNA as an Evolving Liquid Biopsy Biomarker for Initial Diagnosis and Therapeutic Nursing in Cancer- An Evolving Aspect in Medical Biotechnology.
    Ray SK; Mukherjee S
    Curr Pharm Biotechnol; 2022; 23(1):112-122. PubMed ID: 33308128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy for precision diagnostics and therapeutics.
    Anitha K; Posinasetty B; Naveen Kumari K; Chenchula S; Padmavathi R; Prakash S; Radhika C
    Clin Chim Acta; 2024 Feb; 554():117746. PubMed ID: 38151071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy in colorectal cancer.
    Najafi S; Majidpoor J; Mortezaee K
    Clin Chim Acta; 2024 Jan; 553():117674. PubMed ID: 38007059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-blood sources of cell-free DNA for cancer molecular profiling in clinical pathology and oncology.
    Ponti G; Manfredini M; Tomasi A
    Crit Rev Oncol Hematol; 2019 Sep; 141():36-42. PubMed ID: 31212145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size distribution of cell-free DNA in oncology.
    Udomruk S; Orrapin S; Pruksakorn D; Chaiyawat P
    Crit Rev Oncol Hematol; 2021 Oct; 166():103455. PubMed ID: 34464717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
    Coco S; Alama A; Vanni I; Fontana V; Genova C; Dal Bello MG; Truini A; Rijavec E; Biello F; Sini C; Burrafato G; Maggioni C; Barletta G; Grossi F
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28492516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
    Srivastava A; Rathore S; Munshi A; Ramesh R
    AAPS J; 2021 Feb; 23(2):30. PubMed ID: 33586060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy in Bladder Cancer.
    Cui Y; Cao M
    Methods Mol Biol; 2023; 2695():111-120. PubMed ID: 37450114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?
    Hofman P; Heeke S; Alix-Panabières C; Pantel K
    Ann Oncol; 2019 Sep; 30(9):1448-1459. PubMed ID: 31228184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy: General Concepts.
    Poulet G; Massias J; Taly V
    Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumor DNA in liquid biopsy: Current diagnostic limitation.
    Liu SC
    World J Gastroenterol; 2024 Apr; 30(15):2175-2178. PubMed ID: 38681986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis, Monitoring, and Prognosis of Liquid Biopsy in Cancer Immunotherapy.
    Kong W; Chen T; Li Y
    Methods Mol Biol; 2023; 2695():127-143. PubMed ID: 37450116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
    Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
    Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods for the Detection of Circulating Biomarkers in Cancer Patients.
    Mondelo-Macía P; Rodríguez-Ces AM; Suárez-Cunqueiro MM; Romay LM
    Adv Exp Med Biol; 2022; 1379():525-552. PubMed ID: 35761006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
    Paulson V; Konnick EQ; Lockwood CH
    Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.